Aximac 1 Tablet
Marketer
Admac Pharma Ltd
Salt Composition
Axitinib (1mg)
Overview Aximac 1 Tablet
Oncaspar (1 tablet) is an anticancer medication indicated for kidney cancer. While it can be administered with or without food, consistent daily timing optimizes therapeutic efficacy. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Strictly adhere to your doctor's prescribed regimen; improper usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include hypertension, arthralgia, and anorexia. Diarrhea and dyspnea can sometimes be severe; manage these with prescribed medication or through adequate hydration. Regular blood pressure monitoring may be recommended. Report severe headache, cognitive impairment, visual disturbances, nausea, or vomiting immediately. Prior to commencing treatment, disclose any thyroid disorders, hepatic impairment, bleeding disorders, or use of antimicrobial agents. Numerous drug interactions are possible; inform your healthcare provider of all concurrent medications. This medication is contraindicated during pregnancy and lactation. Women of childbearing potential should utilize effective contraception throughout treatment.
Primary Ingredients of Aximac 1 Tablet
No information provided. A rephrased version cannot be created.
Uses of Aximac 1 Tablet
Renal cell carcinoma
Major Benefits of Aximac 1 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Aximac 1 Tablet can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Aximac 1 Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Aximac 1 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Aximac 1 Tablet can be administered with or without food, although consistent timing is recommended.
How Aximac 1 Tablet works:
One Aximac tablet is an anticancer drug that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with Aximac 1 Tablet is undetermined. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Taking Aximac 1 Tablet during pregnancy poses a known risk to the fetus. Its use should be avoided, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the clear dangers. Always seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Aximac 1 Tablet while breastfeeding is likely unsafe. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking one Aximac tablet may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Aximac 1 Tablet presents no safety concerns for patients with kidney impairment and requires no dosage modification.
LiverCAUTION
Patients with liver impairment should use Aximac 1 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Data regarding Aximac 1 Tablet's use in individuals with severe hepatic dysfunction is limited.
What if you forget to take Aximac 1 Tablet :
NA
Facts to Know About Aximac 1 Tablet
| Label | Value |
|---|---|
| Chemical Type | Indazole and Enzamide Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Behavior Class | TKIs (tyrosine kinase inhibitors) |



